Two Pregnancies with a Different Outcome in a Patient with Alport Syndrome
DOI:
https://doi.org/10.3889/oamjms.2016.073Keywords:
Alport syndrome, chronic kidney disease, pregnancyAbstract
BACKGROUND: Alport syndrome is a genetic disease that progresses to chronic kidney failure, with X-linked, autosomal dominant or autosomal recessive type of inheritance. Women are generally carriers of the mutation and have a milder form of the disease. During pregnancy, they have an increased risk of impaired kidney function and preeclampsia.
CASE PRESENTATION: A 27-year old woman, gravida 1, para 0, in her 23rd gestational week came to the outpatient unit of the University Clinic of Nephrology for the first time because of slowly progressing proteinuria and Alport syndrome. She was admitted to the gynaecological ward in her 29th gw for proteinuria which increased from 3.8 g/day up to 20 g/day and the serum creatinine increased to 120- 150 micromol/l. She was delivered in the 30th gestational week due to obstetrical indications with a cesarian section and delivered a baby with a birth weight of 880 g. After delivery, proteinuria decreased to 2 g/d within 2 months and an angiotensin-converting enzyme inhibitor (ACEI) was started. Her second pregnancy, after 2 years, had an uneventful course and she delivered a healthy baby weighing 3000 g in the 39th week. Six months after the second delivery, her renal function remained normal and her proteinuria was 2 g/d.
CONCLUSIONS: Pre-pregnancy counselling and frequent controls during pregnancy are necessary for women with Alport syndrome, as well as regular monitoring after delivery. Recent reports are more in favour of good pregnancy and nephrological outcomes in women with Alport syndrome when renal disease is not advanced.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Chapter in a book: Sessa A, Conte F, Meroni F, Battini G. Alport Syndrome: clinical and genetic correlation in a type IV collagen. Hereditary kidney diseases, Karger, 1996.
Barker DF, Hostikka SL, Zhou J et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248(4960):1224–27. http://dx.doi.org/10.1126/science.2349482 PMid:2349482
Rheault NM. Women and Alport syndrome. Pediatr Nephrol. 2012;27:41–46. http://dx.doi.org/10.1007/s00467-011-1836-7 PMid:21380623 PMCid:PMC3223569
Fischer MJ, Lehnerz SD, Hebert JR, Parikh CR. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis. 2004;43:415-23. http://dx.doi.org/10.1053/j.ajkd.2003.10.041 PMid:14981599
Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008; 336(7637):211-5. http://dx.doi.org/10.1136/bmj.39406.652986.BE PMid:18219043 PMCid:PMC2213870
Nevis IF, Reitsma A, Dominic A, McDonad S, Thabane L et al. Pregnancy Outcomes in Women with Chronic Kidney Disease: A Systematic Review. CJASN. 2011;6:112587-2598. http://dx.doi.org/10.2215/CJN.10841210 PMid:21940842 PMCid:PMC3359575
Jungers P, Houillier P, Forget D, Labrunie M, Skhiri H, Giatras I, et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet. 1995;346:1122-4. http://dx.doi.org/10.1016/S0140-6736(95)91798-5
Shimizu Y, Nagata M, Usui J, Hirayama K, Yoh K, Yamagata K, et al. Nephrol Dial Transplant. 2006;21(6):1582-7. http://dx.doi.org/10.1093/ndt/gfl051 PMid:16517570
Matsuo K, Tudor EL, Baschat AA., Alport syndrome and pregnancy. Obstet Gynecol. 2007;109(2):531-2. http://dx.doi.org/10.1097/01.AOG.0000240141.26395.82 PMid:17267885
Crovetto F,Moroni G, Zaina B, Acaia B, Ossola MW, Fedele L. Pregnancy in women with Alport syndrome. J Obstet Gynaecol. 2014;34(1):98-100.
Matsubara S, Muto S. Good obstetric outcome of consecutive pregnancies in a woman with Alport syndrome. Arch Gynecol Obstet. 2012; 286(1):261-2. http://dx.doi.org/10.1007/s00404-012-2225-6 PMid:22262491
Matsubara S, Ueda Y, Takahashi H, Nagai T, Kuwata T, Muto S, et al. Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunofluorescence staining. J Obstet Gynaecol Res. 2009;35(6):1109-14. http://dx.doi.org/10.1111/j.1447-0756.2009.01069.x PMid:20144175
Alessi M, Fabris A, Zambon A, Cremasco D, Muraro E, Dosa L, et al. Pregnancy in Alport syndrome: a report of two differently-evolving cases. J Obstet Gynaecol. 2014; 34(1):98-100. http://dx.doi.org/10.3109/01443615.2013.834299 PMid:24359068
Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R et al.Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int. 2012; 81:779–783. http://dx.doi.org/10.1038/ki.2011.452 PMid:22237748
Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013; 24(3):364-75. http://dx.doi.org/10.1681/ASN.2012020148 PMid:23349312
Nishizawa Y, Takei T, Miyaoka T, Kamei D, Mochizuki T, Nitta K. Alport syndrome and pregnancy: Good obstetric and nephrological outcomes in a pregnant woman with homozygous autosomal recessive Alport syndrome. J Obstet Gynaecol Res. 2016; 42(3):331-5. http://dx.doi.org/10.1111/jog.12897 PMid:26628290
Yefet E, Tovbin D, Nachum Z. Pregnancy outcomes in patients with Alport syndrome.Arch Gynecol Obstet. 2016; 293(4):739-47. http://dx.doi.org/10.1007/s00404-015-3893-9 PMid:26411580
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0